Lose Weight, Feel Better, Be Happy!
Compounded Semaglutide or Tirzepatide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been approved by the FDA under the brand name Wegovy® for weight loss.
Semaglutide is prescribed as an adjunct to a reduced calorie diet and exercise for those individuals with an elevated body mass index (BMI).
Tirzepatide is a glucagon-like peptide-1 (GLP-1) and a Glucose-dependent insulinotropic polypeptide (GIP) known under the brand name Mounjaro. It is currently being studied for weight loss and is used off label for weight loss. Studies are showing great success with this medication.
Weight Loss with SEMAGLUTIDE or TIRZEPATIDE can:
- Reduce Food Cravings
- Provide slow sustained healthy weight loss
- Slow Gastric Emptying
- Decrease Appetite
- Improves Insulin Resistance
Semaglutide and Tirzepatide are great peptides to combat against insulin resistance and help maintain a healthy weight.
FDA Approved
A research-backed way to lose an average of 15% of body weight with compounded SEMAGLUTIDE or TIRZEPATIDE
GLP-1 Receptor Agonist
Works by mimicking a hormone called glp-1 that targets areas of the brain that regulate appetitie and food intake.
Consistent & Predictable
Administered subcutaneously, once a week. Medication is delivered directly to your door.
$349* / vial for Semaglutide $499* / vial for Tirzepatide Initial start-up will last approximately 8-10 weeks!
*Semaglutide initial startups are $549. The first vial will last 10 injections or 10 weeks then $349 per vial thereafter. A vial of medicine will last 5 weeks on max dosing. Most patients get 6-8 weeks per vial.
* Tirzepatide initial startups are $699. The first vial will last 8 injections or 8 weeks then $499 per vial thereafter.